Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Key Figures

15.12.2025
Key Figures 15.12.2025
Key Figures 15.12.2025
Partners Group’s announcement of AuM as of 31 December 2025
Partners Group’s announcement of AuM as of 31 December 2025
Partners Group’s announcement of AuM as of 31 December 2025
Swiss Life: change on the Board of Directors in the coming year
Swiss Life: change on the Board of Directors in the coming year
Swiss Life: change on the Board of Directors in the coming year
HBM Healthcare Investments Announces Agreement to Sell Majority of Investment in Swixx Biopharma
HBM Healthcare Investments Announces Agreement to Sell Majority of Investment in Swixx Biopharma
HBM Healthcare Investments Announces Agreement to Sell Majority of Investment in Swixx Biopharma
AM Best confirms the rating of Helvetia Swiss Insurance Company Ltd with stable outlook and removes “under review” status
AM Best confirms the rating of Helvetia Swiss Insurance Company Ltd with stable outlook and removes “under review” status
AM Best confirms the rating of Helvetia Swiss Insurance Company Ltd with stable outlook and removes “under review” status
Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million
Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million
Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million
Helvetia Baloise publishes Pro Forma Financial Information
Helvetia Baloise publishes Pro Forma Financial Information
Helvetia Baloise publishes Pro Forma Financial Information
Completion of merger to form Helvetia Baloise Holding Ltd
Completion of merger to form Helvetia Baloise Holding Ltd
Completion of merger to form Helvetia Baloise Holding Ltd
Carsten Stolz to leave the Baloise Group as of 31 December 2025
Carsten Stolz to leave the Baloise Group as of 31 December 2025
Carsten Stolz to leave the Baloise Group as of 31 December 2025
Swiss Prime Site acquires modern office property in Zurich
Swiss Prime Site acquires modern office property in Zurich
Swiss Prime Site acquires modern office property in Zurich
Change in the Board of Directors
Change in the Board of Directors
Change in the Board of Directors
Key Figures

30.11.2025
Key Figures 30.11.2025
Key Figures 30.11.2025
Helvetia and Baloise confirm the completion date of 5 December 2025 for their merger
Helvetia and Baloise confirm the completion date of 5 December 2025 for their merger
Helvetia and Baloise confirm the completion date of 5 December 2025 for their merger
Baloise and Helvetia confirm the completion date of 5 December 2025 for their merger
Baloise and Helvetia confirm the completion date of 5 December 2025 for their merger
Baloise and Helvetia confirm the completion date of 5 December 2025 for their merger
Innoguer GmbH wins the 2025 InnoPrix SO! for its biodegradable high-performance golf ball
Innoguer GmbH wins the 2025 InnoPrix SO! for its biodegradable high-performance golf ball
Innoguer GmbH wins the 2025 InnoPrix SO! for its biodegradable high-performance golf ball
Partners Group portfolio company Esentia Energy Development prices IPO and lists on Mexican Stock Exchange
Partners Group portfolio company Esentia Energy Development prices IPO and lists on Mexican Stock Exchange
Partners Group portfolio company Esentia Energy Development prices IPO and lists on Mexican Stock Exchange
Cembra appoints Bernardo de Barros Franco as Chief Customer & Growth Officer
Cembra appoints Bernardo de Barros Franco as Chief Customer & Growth Officer
Cembra appoints Bernardo de Barros Franco as Chief Customer & Growth Officer
Key Figures

15.11.2025
Key Figures 15.11.2025
Key Figures 15.11.2025
Baloise again recognised as one of the most innovative companies in the Swiss insurance industry in 2025
Baloise again recognised as one of the most innovative companies in the Swiss insurance industry in 2025
Baloise again recognised as one of the most innovative companies in the Swiss insurance industry in 2025
Partners Group appoints Nicholas Smith Wang as Partner and Co-Head of Private Equity Technology
Partners Group appoints Nicholas Smith Wang as Partner and Co-Head of Private Equity Technology
Partners Group appoints Nicholas Smith Wang as Partner and Co-Head of Private Equity Technology
Swiss Life continues to grow in the first nine months of 2025
Swiss Life continues to grow in the first nine months of 2025
Swiss Life continues to grow in the first nine months of 2025
Solid results in the first three quarters of 2025 reflect the robust development of our portfolio.
Solid results in the first three quarters of 2025 reflect the robust development of our portfolio.
Solid results in the first three quarters of 2025 reflect the robust development of our portfolio.
Mobimo Holding AG: Changes to the Board of Directors and business update
Mobimo Holding AG: Changes to the Board of Directors and business update
Mobimo Holding AG: Changes to the Board of Directors and business update
Positive half-year result as at 30 September 2025
Positive half-year result as at 30 September 2025
Positive half-year result as at 30 September 2025
Private Equity Holding AG: Half Year-Report as of September 30, 2025
Private Equity Holding AG: Half Year-Report as of September 30, 2025
Private Equity Holding AG: Half Year-Report as of September 30, 2025